Posts

Trump Issues Executive Order Overhauling Pediatric Vaccine Recommendations

on

Trump floats countdown to 200% tariffs on generic drugs imported to US

on

Trump Reportedly Planning to Fire FDA Commissioner Marty Makary

on

Regeneron Among Remaining Holdouts in Trump's Most-Favored-Nation Drug Pricing Deals

on

Trump Signs Executive Order to Fast-Track FDA Reviews of Psychedelic Drugs Following Joe Rogan Lobbying

on

Trump Announces Up to 100% Tariffs on Imported Patented Drugs

on

Biopharma Bites: PhRMA Rebukes Trump's MFN Call, Pfizer Exercises Beam Base Editing Option, and Charles River Updates

on

Trump Unveils 'The Great Healthcare Plan' to Lower Drug Prices and Target Insurers

on

FDA Advances Real-World Data Use and Early-Phase Trial Reforms to Accelerate Drug Approvals

on

Trump Announces Sweeping Cost Cuts on Lilly and Novo Weight Loss Drugs in Exchange for Medicare Coverage

on

No Trump Drug Pricing Plan for J&J—Yet

on

Trump Administration and Pfizer Strike 'Most Favored Nation' Drug Price Deal

on

Trump Administration Pauses Pharmaceutical Tariffs to Negotiate Industry Agreements

on

Trump Administration Teases MFN Drug Pricing Rule as Commitment Deadline Looms for Companies

on

Trump Administration Launches Tariff Probe into Medtech and Pharmaceutical Industries

on

Trump Administration Weighs Severe Restrictions on US Pharmas Licensing Chinese Medicines

on

Japan Wins Exemption for Generics in US-Japan Trade Deal

on

Trump’s Most Favored Nation Policy and EU Generics: Recent Developments

on

US to Stockpile Critical Drug Ingredients Under Latest Trump Executive Order

on

Trump Announces Massive Pharma Tariffs Up to 250%, Signals Enforcement Within Days

on